Across TCGA pan-cancer cohorts, OR9K1P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of OR9K1P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where OR9K1P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR9K1P is over-expressed in tumor.

HNSC, LUSC, and BLCA are the cancer types where OR9K1P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR9K1P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.139	.001	7	view →
LUSC	Female	All	+0.833	<.001	6	view →
BLCA	All	All	+0.482	.030	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: OR9K1P RNA expression & survival · all OR9K1P data types